{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:04:06Z","timestamp":1787897046203,"version":"build-2784847793"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["R01MH109320"],"award-info":[{"award-number":["R01MH109320"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10461-020-03054-2","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T15:03:19Z","timestamp":1602514999000},"page":"1001-1012","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["DOT Diary: Developing a Novel Mobile App Using Artificial Intelligence and an Electronic Sexual Diary to Measure and Support PrEP Adherence Among Young Men Who Have Sex with Men"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0320-823X","authenticated-orcid":false,"given":"Albert Y.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole D.","family":"Laborde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vittinghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie L.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Ikeguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Shafner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Sunshine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"van der Straten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Siegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Buchbinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"3054_CR1","unstructured":"Centers for Disease Control and Prevention. HIV Surveillance Report, 2017. 2017; https:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Accessed June 2, 2019."},{"key":"3054_CR2","unstructured":"Centers for Disease Control and Prevention. CDC Fact Sheet: HIV among Gay and Bisexual Men. February 2019; www.cdc.gov\/nchhstp\/newsroom\/docs\/factsheets\/cdc-msm-508.pdf. Accessed June 2, 2019."},{"key":"3054_CR3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2019.1343","volume":"321","author":"AS Fauci","year":"2019","unstructured":"Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321:844\u20135.","journal-title":"JAMA"},{"issue":"27","key":"3054_CR4","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587\u201399.","journal-title":"N Engl J Med"},{"issue":"5","key":"3054_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399\u2013410.","journal-title":"N Engl J Med"},{"issue":"5","key":"3054_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423\u201334.","journal-title":"N Engl J Med"},{"issue":"9883","key":"3054_CR7","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083\u201390.","journal-title":"Lancet"},{"issue":"23","key":"3054_CR8","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","volume":"373","author":"JM Molina","year":"2015","unstructured":"Molina JM, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237\u201346.","journal-title":"N Engl J Med"},{"issue":"9","key":"3054_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","volume":"14","author":"RM Grant","year":"2014","unstructured":"Grant RM, Anderson PL, McMahan V, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"10013","key":"3054_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","volume":"387","author":"S McCormack","year":"2016","unstructured":"McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53\u201360.","journal-title":"Lancet"},{"issue":"1","key":"3054_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","volume":"176","author":"AY Liu","year":"2016","unstructured":"Liu AY, Cohen SE, Vittinghoff E, et al. Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Intern Med. 2016;176(1):75\u201384.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"3054_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/QAI.0000000000001129","volume":"73","author":"JL Marcus","year":"2016","unstructured":"Marcus JL, Hurley LB, Hare CB, et al. Preexposure prophylaxis for HIV prevention in a large integrated health care system: adherence, renal safety, and discontinuation. J Acquir Immune Defic Syndr. 2016;73(5):540\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"3054_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/QAI.0000000000001179","volume":"74","author":"SG Hosek","year":"2017","unstructured":"Hosek SG, Rudy B, Landovitz R, et al. An HIV preexposure prophylaxis demonstration project and safety study for young MSM. J Acquir Immune Defic Syndr. 2017;74(1):21\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"3054_CR14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jamapediatrics.2017.2007","volume":"171","author":"SG Hosek","year":"2017","unstructured":"Hosek SG, Landovitz RJ, Kapogiannis B, et al. Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States. JAMA Pediatr. 2017;171(11):1063\u201371.","journal-title":"JAMA Pediatr"},{"issue":"2","key":"3054_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/cid\/cix755","volume":"66","author":"CA Koss","year":"2018","unstructured":"Koss CA, Hosek SG, Bacchetti P, et al. Comparison of measures of adherence to human immunodeficiency virus preexposure prophylaxis among adolescent and young men who have sex with men in the United States. Clin Infect Dis. 2018;66(2):213\u20139.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3054_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/QAI.0b013e3182801081","volume":"62","author":"SG Hosek","year":"2013","unstructured":"Hosek SG, Siberry G, Bell M, et al. The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men. J Acquir Immune Defic Syndr. 2013;62(4):447\u201356.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"3054_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411\u201322.","journal-title":"N Engl J Med"},{"issue":"6","key":"3054_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509\u201318.","journal-title":"N Engl J Med"},{"issue":"5","key":"3054_CR19","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/JCP.0000000000000372","volume":"35","author":"DJ McCann","year":"2015","unstructured":"McCann DJ, Petry NM, Bresell A, Isacsson E, Wilson E, Alexander RC. Medication nonadherence, \"professional subjects,\" and apparent placebo responders: overlapping challenges for medications development. J Clin Psychopharmacol. 2015;35(5):566\u201373.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"3054_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/YIC.0000000000000145","volume":"32","author":"AH Clayton","year":"2017","unstructured":"Clayton AH, Durgam S, Li D, et al. Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study. Int Clin Psychopharmacol. 2017;32(1):27\u201335.","journal-title":"Int Clin Psychopharmacol"},{"issue":"4","key":"3054_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/0269881119832538","volume":"33","author":"J Biederman","year":"2019","unstructured":"Biederman J, Lindsten A, Sluth LB, et al. Vortioxetine for attention deficit hyperactivity disorder in adults: a randomized, double-blind, placebo-controlled, proof-of-concept study. J Psychopharmacol. 2019;33(4):511\u201321.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"3054_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/bcp.12942","volume":"82","author":"M El Alili","year":"2016","unstructured":"El Alili M, Vrijens B, Demonceau J, Evers SM, Hiligsmann M. A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol. 2016;82(1):268\u201379.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"3054_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/ijn.12100","volume":"19","author":"WA Reich","year":"2013","unstructured":"Reich WA. Medication adherence feedback intervention predicts improved human immunodeficiency virus clinical markers. Int J Nurs Pract. 2013;19(6):577\u201383.","journal-title":"Int J Nurs Pract"},{"key":"3054_CR24","first-page":"957862","volume":"2013","author":"M Bachman Desilva","year":"2013","unstructured":"Bachman Desilva M, Gifford AL, Keyi X, et al. Feasibility and acceptability of a real-time adherence device among HIV-positive IDU patients in China. AIDS Res Treat. 2013;2013:957862.","journal-title":"AIDS Res Treat"},{"key":"3054_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/aid.2019.0202","volume":"36","author":"H Liu","year":"2019","unstructured":"Liu H, Daar ES, Wang Y, et al. Pharmacokinetics of Co-encapsulated antiretrovirals with ingestible sensors. AIDS Res Hum Retroviruses. 2019;36:65\u201374.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"3054_CR26","doi-asserted-by":"publisher","first-page":"e246","DOI":"10.2196\/jmir.7833","volume":"19","author":"J Frias","year":"2017","unstructured":"Frias J, Virdi N, Raja P, Kim Y, Savage G, Osterberg L. Effectiveness of digital medicines to improve clinical outcomes in patients with uncontrolled hypertension and type 2 diabetes: prospective, open-label, cluster-randomized pilot clinical trial. J Med Internet Res. 2017;19(7):e246.","journal-title":"J Med Internet Res"},{"issue":"1","key":"3054_CR27","doi-asserted-by":"publisher","first-page":"e53373","DOI":"10.1371\/journal.pone.0053373","volume":"8","author":"R Belknap","year":"2013","unstructured":"Belknap R, Weis S, Brookens A, et al. Feasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapy. PLoS ONE. 2013;8(1):e53373.","journal-title":"PLoS ONE"},{"issue":"2","key":"3054_CR28","doi-asserted-by":"publisher","first-page":"026006","DOI":"10.1088\/1752-7155\/1\/2\/026006","volume":"1","author":"VV Meka","year":"2007","unstructured":"Meka VV, Lutz BJ, Melker RJ, Euliano NR. Prototype of a breath-based analysis system for medication compliance monitoring. J Breath Res. 2007;1(2):026006.","journal-title":"J Breath Res"},{"issue":"1","key":"3054_CR29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s10461-012-0318-7","volume":"17","author":"TE Morey","year":"2013","unstructured":"Morey TE, Booth M, Wasdo S, et al. Oral adherence monitoring using a breath test to supplement highly active antiretroviral therapy. AIDS Behav. 2013;17(1):298\u2013306.","journal-title":"AIDS Behav"},{"issue":"1","key":"3054_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/0091270011434157","volume":"53","author":"TE Morey","year":"2013","unstructured":"Morey TE, Wasdo S, Wishin J, et al. Feasibility of a breath test for monitoring adherence to vaginal administration of antiretroviral microbicide gels. J Clin Pharmacol. 2013;53(1):103\u201311.","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"3054_CR31","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/jcph.689","volume":"56","author":"TM Shiovitz","year":"2016","unstructured":"Shiovitz TM, Bain EE, McCann DJ, et al. Mitigating the effects of nonadherence in clinical trials. J Clin Pharmacol. 2016;56(9):1151\u201364.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"3054_CR32","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.2196\/mhealth.7030","volume":"5","author":"EE Bain","year":"2017","unstructured":"Bain EE, Shafner L, Walling DP, et al. Use of a novel artificial intelligence platform on mobile devices to assess dosing compliance in a phase 2 clinical trial in subjects with schizophrenia. JMIR mHealth and uHealth. 2017;5(2):e18.","journal-title":"JMIR mHealth and uHealth"},{"issue":"5","key":"3054_CR33","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1161\/STROKEAHA.116.016281","volume":"48","author":"DL Labovitz","year":"2017","unstructured":"Labovitz DL, Shafner L, Reyes Gil M, Virmani D, Hanina A. Using artificial intelligence to reduce the risk of nonadherence in patients on anticoagulation therapy. Stroke. 2017;48(5):1416\u20139.","journal-title":"Stroke"},{"issue":"4","key":"3054_CR34","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.2196\/jmir.6838","volume":"19","author":"C Ernsting","year":"2017","unstructured":"Ernsting C, Dombrowski SU, Oedekoven M, et al. Using smartphones and health apps to change and manage health behaviors: a population-based survey. J Med Internet Res. 2017;19(4):e101.","journal-title":"J Med Internet Res"},{"issue":"4","key":"3054_CR35","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.2196\/jmir.2583","volume":"15","author":"L Dennison","year":"2013","unstructured":"Dennison L, Morrison L, Conway G, Yardley L. Opportunities and challenges for smartphone applications in supporting health behavior change: qualitative study. J Med Internet Res. 2013;15(4):e86.","journal-title":"J Med Internet Res"},{"issue":"12","key":"3054_CR36","first-page":"2383","volume":"15","author":"M Lee","year":"2018","unstructured":"Lee M, Lee H, Kim Y, et al. Mobile app-based health promotion programs: a systematic review of the literature. Int J Environ Res Public Health. 2018;15(12):2383.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"3054_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/OLQ.0b013e3181f68d7b","volume":"38","author":"J Gold","year":"2011","unstructured":"Gold J, Lim MS, Hocking JS, Keogh LA, Spelman T, Hellard ME. Determining the impact of text messaging for sexual health promotion to young people. Sex Transm Dis. 2011;38(4):247\u201352.","journal-title":"Sex Transm Dis"},{"issue":"5\u20136","key":"3054_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10935-012-0282-z","volume":"33","author":"IW Holloway","year":"2012","unstructured":"Holloway IW, Cederbaum JA, Ajayi A, Shoptaw S. Where are the young men in HIV prevention efforts? Comments on HIV prevention programs and research from young men who sex with men in Los Angeles county. J Prim Prev. 2012;33(5\u20136):271\u20138.","journal-title":"J Prim Prev"},{"issue":"3","key":"3054_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11524-010-9456-2","volume":"87","author":"KM Eyrich-Garg","year":"2010","unstructured":"Eyrich-Garg KM. Mobile phone technology: a new paradigm for the prevention, treatment, and research of the non-sheltered \"street\" homeless? J Urban Health. 2010;87(3):365\u201380.","journal-title":"J Urban Health"},{"issue":"1","key":"3054_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13142-011-0021-7","volume":"1","author":"WT Riley","year":"2011","unstructured":"Riley WT, Rivera DE, Atienza AA, Nilsen W, Allison SM, Mermelstein R. Health behavior models in the age of mobile interventions: are our theories up to the task? Transl Behav Med. 2011;1(1):53\u201371.","journal-title":"Transl Behav Med"},{"issue":"4","key":"3054_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/apc.2012.0404","volume":"27","author":"KE Muessig","year":"2013","unstructured":"Muessig KE, Pike EC, Fowler B, et al. Putting prevention in their pockets: developing mobile phone-based HIV interventions for black men who have sex with men. AIDS Pat Care STDS. 2013;27(4):211\u201322.","journal-title":"AIDS Pat Care STDS"},{"key":"3054_CR42","unstructured":"Chang A, Shafner L, Hernandez A, Hanina A. Evaluating the use of an artificial intelligence (AI) platform on mobile devices to measure and support tuberculosis medication adherence. Paper presented at: End TB 2019: 23rd Annual Conference of the Union North America Region2017; Vancouver, Canada"},{"key":"3054_CR43","doi-asserted-by":"crossref","unstructured":"Salcedo J, Rosales M, Nuno D, Suen S-C, Chang A. Cost-Effectiveness of Novel Artificial Intelligence Platform Aicure for Active Tuberculosis Treatment in Los Angeles County. Paper presented at: Society for Medical Decision Making. 40th Annual North American Meeting 2018; Montreal, Canada.","DOI":"10.1016\/j.jval.2019.04.895"},{"key":"3054_CR44","unstructured":"Samaddar A, Abbas A, Shafner L, Galatzer-Levy I. Assessing an Artificial Intelligence platform to accurately predict pharmacokinetic sampling outcomes in CNS trials. Paper presented at: Schizophrenia International Research SocietyApril 2019"},{"issue":"3","key":"3054_CR45","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12160-013-9549-8","volume":"47","author":"ME Newcomb","year":"2014","unstructured":"Newcomb ME, Mustanski B. Diaries for observation or intervention of health behaviors: factors that predict reactivity in a sexual diary study of men who have sex with men. Ann Behav Med. 2014;47(3):325\u201334.","journal-title":"Ann Behav Med"},{"issue":"5","key":"3054_CR46","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/sextrans-2013-051472","volume":"90","author":"C Stalgaitis","year":"2014","unstructured":"Stalgaitis C, Glick SN. The use of web-based diaries in sexual risk behaviour research: a systematic review. Sex Transm Infect. 2014;90(5):374\u201381.","journal-title":"Sex Transm Infect"},{"issue":"2","key":"3054_CR47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/00042560-200206010-00006","volume":"30","author":"JW Dilley","year":"2002","unstructured":"Dilley JW, Woods WJ, Sabatino J, et al. Changing sexual behavior among gay male repeat testers for HIV: a randomized, controlled trial of a single-session intervention. J Acquir Immune Defic Syndr. 2002;30(2):177\u201386.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"3054_CR48","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/09540120512331314303","volume":"17","author":"A Carballo-Dieguez","year":"2005","unstructured":"Carballo-Dieguez A, Dolezal C, Leu CS, et al. A randomized controlled trial to test an HIV-prevention intervention for Latino gay and bisexual men: lessons learned. AIDS Care. 2005;17(3):314\u201328.","journal-title":"AIDS Care"},{"issue":"7","key":"3054_CR49","doi-asserted-by":"publisher","first-page":"e0201166","DOI":"10.1371\/journal.pone.0201166","volume":"13","author":"K Lee","year":"2018","unstructured":"Lee K, Kwon H, Lee B, et al. Effect of self-monitoring on long-term patient engagement with mobile health applications. PLoS ONE. 2018;13(7):e0201166.","journal-title":"PLoS ONE"},{"issue":"8","key":"3054_CR50","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.2105\/AJPH.2014.302041","volume":"104","author":"PA Grady","year":"2014","unstructured":"Grady PA, Gough LL. Self-management: a comprehensive approach to management of chronic conditions. Am J Public Health. 2014;104(8):e25\u201331.","journal-title":"Am J Public Health"},{"issue":"1","key":"3054_CR51","doi-asserted-by":"publisher","first-page":"e10659","DOI":"10.2196\/10659","volume":"8","author":"A Liu","year":"2019","unstructured":"Liu A, Coleman K, Bojan K, et al. Developing a Mobile App (LYNX) to support linkage to HIV\/sexually transmitted infection testing and pre-exposure prophylaxis for young men who have sex with men: protocol for a randomized controlled trial. JMIR Res Protoc. 2019;8(1):e10659.","journal-title":"JMIR Res Protoc"},{"key":"3054_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01710-17","volume":"62","author":"PL Anderson","year":"2018","unstructured":"Anderson PL, Liu AY, Castillo-Mancilla JR, et al. Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy. Antimicrob Agents Chemother. 2018;62:1.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3054_CR53","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1089\/aid.2012.0089","volume":"29","author":"JR Castillo-Mancilla","year":"2013","unstructured":"Castillo-Mancilla JR, Zheng JH, et al. Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Res Hum Retroviruses. 2013;29(2):384\u201390.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"151","key":"3054_CR54","doi-asserted-by":"publisher","first-page":"151ra125","DOI":"10.1126\/scitranslmed.3004006","volume":"4","author":"PL Anderson","year":"2012","unstructured":"Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.","journal-title":"Sci Transl Med"},{"issue":"3","key":"3054_CR55","doi-asserted-by":"publisher","first-page":"e1001613","DOI":"10.1371\/journal.pmed.1001613","volume":"11","author":"A Liu","year":"2014","unstructured":"Liu A, Cohen S, Follansbee S, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11(3):e1001613.","journal-title":"PLoS Med"},{"key":"3054_CR56","first-page":"189","volume-title":"Usability evaluation in industry","author":"J Brooke","year":"1996","unstructured":"Brooke J. SUS: a \"quick and dirty\u201f usability scale. In: Jordan P, Thomas B, Weerdmeester B, McClelland I, editors. Usability evaluation in industry. London: Taylor and Francis; 1996. p. 189\u2013194."},{"issue":"3","key":"3054_CR57","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0149-7189(79)90094-6","volume":"2","author":"DL Larsen","year":"1979","unstructured":"Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client\/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197\u2013207.","journal-title":"Eval Program Plann"},{"issue":"3","key":"3054_CR58","first-page":"114","volume":"4","author":"A Bangor","year":"2009","unstructured":"Bangor A, Kortum P, Miller J. Determining what individual SUS scores mean: adding an adjective rating scale. J Usabil Stud. 2009;4(3):114\u201323.","journal-title":"J Usabil Stud"},{"issue":"8","key":"3054_CR59","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S0002-9343(01)00695-7","volume":"110","author":"RE Chaisson","year":"2001","unstructured":"Chaisson RE, Barnes GL, Hackman J, et al. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Am J Med. 2001;110(8):610\u20135.","journal-title":"Am J Med"},{"issue":"2","key":"3054_CR60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/QAI.0b013e3181d9a330","volume":"54","author":"JE Hart","year":"2010","unstructured":"Hart JE, Jeon CY, Ivers LC, et al. Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review. J Acquir Immune Defic Syndr. 2010;54(2):167\u201379.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 2","key":"3054_CR61","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.1097\/QAD.0000000000000252","volume":"28","author":"KH Chaiyachati","year":"2014","unstructured":"Chaiyachati KH, Ogbuoji O, Price M, Suthar AB, Negussie EK, Barnighausen T. Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. AIDS. 2014;28(Suppl 2):S187\u2013204.","journal-title":"AIDS"},{"issue":"3","key":"3054_CR62","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1017\/S0266462313000317","volume":"29","author":"T Mathes","year":"2013","unstructured":"Mathes T, Pieper D, Antoine SL, Eikermann M. Cost-effectiveness of adherence interventions for highly active antiretroviral therapy: a systematic review. Int J Technol Assess Health Care. 2013;29(3):227\u201333.","journal-title":"Int J Technol Assess Health Care"},{"issue":"1","key":"3054_CR63","first-page":"11","volume":"73","author":"D Hu","year":"2014","unstructured":"Hu D, Juarez DT, Yeboah M, Castillo TP. Interventions to increase medication adherence in African-American and Latino populations: a literature review. Hawai'i J Med Public Health. 2014;73(1):11\u20138.","journal-title":"Hawai'i J Med Public Health"},{"issue":"2","key":"3054_CR64","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/apc.2007.0063","volume":"22","author":"M Ma","year":"2008","unstructured":"Ma M, Brown BR, Coleman M, Kibler JL, Loewenthal H, Mitty JA. The feasibility of modified directly observed therapy for HIV-seropositive African American substance users. AIDS Pat Care STDS. 2008;22(2):139\u201346.","journal-title":"AIDS Pat Care STDS"},{"issue":"6","key":"3054_CR65","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/OLQ.0000000000000999","volume":"46","author":"RNN Finkenflugel","year":"2019","unstructured":"Finkenflugel RNN, Hoornenborg E, Achterbergh RCA, et al. A mobile application to collect daily data on preexposure prophylaxis adherence and sexual behavior among men who have sex with men: use over time and comparability with conventional data collection. Sex Transm Dis. 2019;46(6):400\u20136.","journal-title":"Sex Transm Dis"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-020-03054-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-020-03054-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-020-03054-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T01:07:36Z","timestamp":1669165656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-020-03054-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["3054"],"URL":"https:\/\/doi.org\/10.1007\/s10461-020-03054-2","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"30 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"AL, AVS and SB have led studies in which Gilead Sciences has donated study drug. AJS is a Co-Investigator on a study funded by Gilead Foundation. AL is Principal Investigator of investigator sponsored research projects funded by Gilead Sciences and Viiv Healthcare. EI, LS, and LS are employees of AiCure. ALT, EV, RG, GW, KC, NL, have no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}